MAPT and Alzheimer disease: AD is a characterized by the abnormal aggregation and deposition of amyloid-β (Aβ) peptides into extracellular plaques and of hyperphosphorylated Tau into intracellular neurofibrillary tangles, followed by synaptic and neuronal loss resulting in progressive cognitive and functional decline.